Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study will assess the safety and efficacy of ARQ-151 cream vs vehicle applied once a day for 4 weeks by subjects with atopic dermatitis (eczema).
Epistemonikos ID: 990af32812a1a59094195c5adbbd1c8ea87f1c05
First added on: May 08, 2024